InVivo Therapeutics to sponsor Working 2 Walk symposium

InVivo Therapeutics Holdings Corp. (NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI) and other neurotrauma conditions, today announced that the Company is the Title Sponsor of the 8^th annual Working 2 Walk Science & Advocacy Symposium taking place September 27-28, 2013 at the Boston Convention & Exhibit Center in Boston, MA.

Working 2 Walk is an annual event held by Unite 2 Fight Paralysis to bring together spinal cord injury research scientists, practitioners, investors and consumers for a discussion of current research and strategies that will accelerate progress toward cures for paralysis. Unite 2 Fight Paralysis is a not-for-profit organization dedicated to the realization of curative therapies. This will be the fifth year that InVivo has participated as a sponsor at the Symposium.

InVivo Therapeutics has developed a treatment that uses a biocompatible polymer-based scaffold to provide structural support to a damaged spinal cord in order to spare tissue from scarring while improving recovery and prognosis after a traumatic SCI. The Company recently received FDA approval to begin a first-in-man clinical trial of the treatment in acute SCI.

Said Frank Reynolds, InVivo Chief Executive Officer, "We are proud to once again be a part of the Working 2 Walk symposium. At the event we will provide an update on our human study, and will also discuss how we're leveraging our materials to develop multiple tissue engineered and tissue regeneration products to treat a range of neurotrauma conditions."